Panbela Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Panbela Therapeutics

15/08/2022 22:53

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of $1.51​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 25 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.51​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had risen by 95.3% this
quarter and lost 25.5% so far this year.
    * The company reported a quarterly loss of $22.31 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:53 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.25          -1.51          Missed
 Mar. 31 2022      -0.25          -0.27          Missed
 Dec. 31 2021      -0.18          -0.26          Missed
 Sep. 30 2021      -0.23          -0.16          Beat